Nvidia got the green light from President Donald Trump to sell its more advanced H200 AI chip to China. But there are questions over whether Beijing will want to buy them given its drive for ...

What if your database could not only answer your queries but also learn from them, growing smarter and more intuitive with every interaction? Imagine an AI-powered agent that understands your intent, ...

My second grader’s public school is full of warm, caring educators and decent support for students working below grade level. His class is big and rowdy, with a single teacher and a majority of kids ...

The median progression-free survival was 9.5 months with tucatinib and 7.4 months without. The PFS benefit was seen even in patients with brain metastases, study researchers reported. The phase 3 ...

The president told reporters in the Oval Office on Monday that he planned to sell the advanced fighter jets to Riyadh. By Karoun Demirjian Reporting from Washington President Trump said on Monday that ...

Our 2-year-old daughter, “Daisy,” started a new daycare program over the summer. Her lead teacher ran an in-home daycare for 20 years before moving to this center, and she has what we consider to be ...

WASHINGTON, Nov 4 (Reuters) - The Trump administration is not planning to allow Nvidia (NVDA.O), opens new tab to sell its most advanced AI chip, known as the Blackwell, to China right now, the White ...

Everyone loves a good alien invasion story, preferably one with city-sized ships and physics-defying tech. There's just one big problem with that. The Milky Way is estimated to contain 100 to 400 ...

For diehard duck hunters, any opportunity to improve downrange lethality is all but irresistible. After all, ducks can be tough, and premium pellet materials like tungsten and bismuth are only getting ...

T-Mobile Business CMO calls 5G-Advanced and network slicing the ‘secret sauce’ behind Edge Control’s ability to route local traffic securely and efficiently T-Mobile US launched Edge Control this week ...

Human epidermal growth factor receptor 2 (HER2)–directed antibody–drug conjugate monotherapy has shown preliminary clinical efficacy in patients with chemotherapy-refractory HER2-positive locally ...